Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/99/5f/12/995f1267-3339-7058-b96e-ee21353fd31f/mza_9203593219483942390.jpg/600x600bb.jpg
The Bellcast
Bell Direct
85 episodes
1 week ago
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed agricultural REIT, its diversified portfolio of farmland, and growth strategy, including its expanding macadamia holdings. Tim and James share insights into RFF’s portfolio composition, market outlook, and how the company is leveraging technology and sus...
Show more...
Investing
Business
RSS
All content for The Bellcast is the property of Bell Direct and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed agricultural REIT, its diversified portfolio of farmland, and growth strategy, including its expanding macadamia holdings. Tim and James share insights into RFF’s portfolio composition, market outlook, and how the company is leveraging technology and sus...
Show more...
Investing
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/99/5f/12/995f1267-3339-7058-b96e-ee21353fd31f/mza_9203593219483942390.jpg/600x600bb.jpg
From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO
The Bellcast
11 minutes
1 month ago
From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO
In this episode of From the Helm, Grady Wulff sits down with Cynata Therapeutics (ASX:CYP) CEO, Kilian Kelly, to discuss the company’s pioneering work in stem cell and regenerative medicine. Kilian shares insights on Cynata’s mesenchymal stromal cell (MSC) platform, its unique “one donor, one time” approach, the path to commercialisation, and what investors can expect in the coming year. In this interview, Grady covers: (0:29) an introduction to Cynata and its core technology(1:05) the role ...
The Bellcast
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed agricultural REIT, its diversified portfolio of farmland, and growth strategy, including its expanding macadamia holdings. Tim and James share insights into RFF’s portfolio composition, market outlook, and how the company is leveraging technology and sus...